CD26-processed RANTES(3–68), but not intact RANTES, has potent anti-HIV-1 activity

Dominique Schols; Paul Proost; Sofie Struyf; Anja Wuyts; Ingrid De Meester; Simon Scharpé; Jo Van Damme; De Clercq Erik

doi:10.1016/s0166-3542(98)00039-4

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1999

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity (vol 39, pg 175, 1998)

Dominique Schols, Paul Proost, Sofie Struyf, Anja Wuyts, Ingrid De Meester, Simon Scharpé, Jo Van Damme, De Clercq Erik

Article1999

CD26/Dipeptidyl-Peptidase IV Down-Regulates the Eosinophil Chemotactic Potency, But Not the Anti-HIV Activity of Human Eotaxin by Affecting Its Interaction with CC Chemokine Receptor 3

Sofie Struyf, Paul Proost, Dominique Schols, De Clercq Erik, Ghislain Opdenakker, Jean‐Pierre Lenaerts, Michel Detheux, Marc Parmentier, Ingrid De Meester, Simon Scharpé, Jo Van Damme

Article2008

Structural Modifications of DAPY Analogues with Potent Anti‐HIV‐1 Activity

Xiaoqing Feng, Yonghong Liang, Zhao‐Sen Zeng, Fen‐Er Chen, Jan Balzarini, Christophe Pannecouque, De Clercq Erik

Article1989

Anti-Hiv-1 Activity of 2′,3′-Dideoxinucleoside Analogues : Structure-Activity Relationship

De Clercq Erik, Arthur Van Aerschot, Piet Herdewijn, Masanori Baba, Rudi Pauwels, Jan Balzarini

Article1998

NH2-terminal processing of chemokines (RANTES, SDF1-alpha) by CD26/dipeptidylpeptidase IV generates inhibitors of chemotaxis and HIV-1 infection

Jo Van Damme, Paul Proost, Sofie Struyf, Anja Wuyts, Anne‐Marie Lambeir, Ingrid De Meester, Dominique Schols, Simon Scharpé, De Clercq Erik